ECL vs TVTX · P/E 35, rev $8.48B vs rev $296.8M
Ecolab Inc (ECL) versus Travere Therapeutics Inc (TVTX) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Latest reported ECL revenue for 2026-06-30 was $8.48B. Net income was $967.5M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported TVTX revenue for 2026-06-30 was $296.8M. Net income was -$71.9M. TVTX currently screens at market cap $1.33B.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. TVTX currently screens at market cap $1.33B.
Not investment advice. Open the ECL and TVTX stock pages for the full models.
Not investment advice.